news
Germany imports largest ever shipment of EU medicinal cannabis
An import of medicinal cannabis from Portugal to Germany signifies the largest quantity ever moved within the EU, highlighting a surge in the medicinal cannabis products market.
List view / Grid view
Packaging & Labelling
news
Federal judge enters consent decree against drug distributors
Two Tennessee companies have been prevented from distributing drugs after a complaint they were supplying unapproved medications.
news
Sandoz issues voluntary recall for medication bottles
The pharmaceutical company has announced a recall for certain prescription drug bottles which do not meet child-resistant regulations.
article
How tablet formulation can impact production
Transforming a formulation into a successful solid dose product is a complex process that involves many considerations. Given the ever-growing demand for increased tablet quantities and the goal of reducing time to market, Rob Blanchard explains how the pressure is on manufacturers to find innovative processes to improve production efficiency.
article
The future of tamper-proof pharmaceutical packaging
In February this year the EU Falsified Medicines Directive (FMD) came into effect. Rich Quelch assesses this latest regulatory attempt to rid the supply chain of dangerous falsified products and reflects on the industry’s need to keep ahead of the game to future-protect itself.
article
Safeguard patients’ safety with extractables and leachables studies
SGS Life Sciences offers tailored study design and testing for extractables and leachables (E&L) in finished pharmaceutical packaging, process equipment and medical devices, and leachables in final product for clients using single-use systems (SUS).
article
Manufacturing, Packaging & Logistics In-Depth Focus 2019
The articles in this In-Depth Focus delve into the effectiveness of the FMD and why it is necessary as well as how drug manufacturers need to become innovative in their processes.
article
European Pharmaceutical Review Issue 4 2019
This issue includes an investigation into the potential for continuous production lines in biopharma, information on new guidance released by China on their regulatory processes and an assessment of the FMD to improve the drug supply chain. Also within the issue are articles on nanomedicine development, monoclonal antibodies and pharmaceutical…
news
17 Spanish infants develop ‘werewolf syndrome’ after drug mislabelling
Young children in Spain have developed hypertrichosis, also known as ‘werewolf syndrome’, after a reflux drug was contaminated with an alopecia treatment.
news
Voluntary recall issued for lidocaine cream and liquid gel products
Lidocaine topical cream and liquid gel products are being recalled as the lidocaine amount is higher than the label states.
news
Liposomal medicine names to be changed to avoid errors
The EMA has requested that liposomal medication names be changed to avoid the risk of confusion.
article
Surge in negative verifications of saleable returns could cost pharma industry billions
The pharmaceutical industry is set to face some major changes in the near future, to improve the quality of returned drugs and medications.
news
Two lots of Kogenate® recalled due to mislabelling
Two lots of Kogenate® FS vials actually contain the FVIII hemophilia A treatment, Jivi®.
news
Drone temperature-controlled medicine delivery programme test completed
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
news
Chinese drug packaging industry set to be worth RMB200 billion
Pharmaceutical packaging in China has increased at a rate of 10 percent in recent years and is predicted to continue high growth.
